These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15668409)

  • 1. Should levodopa be infused into the duodenum?
    Mouradian MM
    Neurology; 2005 Jan; 64(2):182-3. PubMed ID: 15668409
    [No Abstract]   [Full Text] [Related]  

  • 2. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D; Nilsson Remahl AI; Dizdar N; Constantinescu R; Holmberg B; Jansson R; Aquilonius SM; Askmark H
    Neurology; 2005 Jan; 64(2):216-23. PubMed ID: 15668416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.
    Antonini A; Isaias IU; Canesi M; Zibetti M; Mancini F; Manfredi L; Dal Fante M; Lopiano L; Pezzoli G
    Mov Disord; 2007 Jun; 22(8):1145-9. PubMed ID: 17661426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced Parkinson's disease with levodopa/carbidopa intestinal gel is associated with improvements in Hoehn and Yahr stage.
    Munro Neville A; Parsons RW; Askmark H; Nyholm D
    Parkinsonism Relat Disord; 2012 Jun; 18(5):686-7. PubMed ID: 22197121
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advanced course of Parkinson disease. Little improved motion with continuous intestinal levodopa administration].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2005 Jul; 28(7):245-6. PubMed ID: 16038123
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Nutt JG
    Neurology; 2006 May; 66(10):1611-2; author reply 1611-2. PubMed ID: 16717244
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
    Nutt JG; Carter JH; Carlson NE
    Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: successful use of rectally administered levodopa-carbidopa.
    Cooper SD; Ismail HA; Frank C
    Can Fam Physician; 2001 Jan; 47():112-3. PubMed ID: 11212422
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion.
    Isacson D; Bingefors K; Kristiansen IS; Nyholm D
    Acta Neurol Scand; 2008 Dec; 118(6):379-86. PubMed ID: 18547273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
    Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Nyholm D; Jansson R; Willows T; Remahl IN
    Neurology; 2005 Nov; 65(9):1506-7. PubMed ID: 16275852
    [No Abstract]   [Full Text] [Related]  

  • 13. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asparagus and jejunal-through-PEG: an unhappy encounter in intrajejunal levodopa infusion therapy.
    Schrader C; Böselt S; Wedemeyer J; Dressler D; Weismüller TJ
    Parkinsonism Relat Disord; 2011 Jan; 17(1):67-9. PubMed ID: 20933456
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion.
    Meiler B; Andrich J; Müller T
    Mov Disord; 2008 Jan; 23(1):145-6. PubMed ID: 17987653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy: anti-Parkinson medication].
    Dambreville F
    Rev Infirm; 1982 Nov; 32(17):51-2. PubMed ID: 6925298
    [No Abstract]   [Full Text] [Related]  

  • 17. Single vs multiple daily dosing of aminoglycosides.
    Newton W
    J Fam Pract; 1996 May; 42(5):456-7. PubMed ID: 8642359
    [No Abstract]   [Full Text] [Related]  

  • 18. Piribedil in Parkinsonism.
    Cane DB
    Adv Neurol; 1974; 5():325. PubMed ID: 4613159
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study.
    Kulisevsky J; Pascual-Sedano B; Barbanoj M; Gironell A; Pagonabarraga J; García-Sánchez C
    Mov Disord; 2007 Jan; 22(1):62-7. PubMed ID: 17115388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate-release and controlled-release carbidopa/levodopa in PD: A 5-year randomized multicenter study.
    Van Horn G; Schiess MC
    Neurology; 2000 Jul; 55(1):156-7. PubMed ID: 10891940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.